|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
3
|
Resverlogix Corp.
|
Jun 06, 2020 01:38PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
3
|
Resverlogix Corp.
|
Dec 01, 2018 09:22PM
|
|
Re: A New Frontier in CV Risk Reduction for Patients With Type 2 Diabetes
|
3
|
Resverlogix Corp.
|
Dec 17, 2018 11:52AM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
3
|
Zenith Epigenetics
|
Apr 12, 2021 11:12AM
|
|
Re: What if RRR MACE is significant at 90% confidence?
|
3
|
Resverlogix Corp.
|
Apr 24, 2018 11:31AM
|
|
Re: Futilitcy analysis
|
3
|
Resverlogix Corp.
|
May 12, 2017 11:23AM
|
|
Zacks SCR Resverlogix Report 12/28/18
|
3
|
Resverlogix Corp.
|
Jan 02, 2019 11:57AM
|
|
Re: MACE Events - Statistically Confusing
|
3
|
Resverlogix Corp.
|
Mar 01, 2019 02:33PM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
3
|
Zenith Epigenetics
|
Jun 16, 2016 10:53AM
|
|
Re: RVX vs AMRN ??
|
3
|
Resverlogix Corp.
|
Feb 14, 2019 01:49PM
|
|
Re: Webcast thoughts
|
3
|
Resverlogix Corp.
|
Jun 17, 2015 01:39PM
|
|
BETonMACE ClinicalTrial.gov updated
|
3
|
Resverlogix Corp.
|
Sep 29, 2017 06:46AM
|
|
Re: If this trial were made up of ONLY placebo patients,..
|
3
|
Resverlogix Corp.
|
Nov 19, 2018 02:44PM
|
|
Re: Update
|
3
|
Resverlogix Corp.
|
Jun 12, 2019 11:21AM
|
|
Re: Odd About The Disappearing Presentation
|
3
|
Resverlogix Corp.
|
May 21, 2017 08:39PM
|
|
Re: April 28 - 29 | Exclusive Digital Event-Triple Negative Breast Cancer
|
3
|
Zenith Epigenetics
|
Feb 12, 2021 09:49AM
|
|
Re: Microcap bought in CVR deal - stock is up 700%
|
3
|
Resverlogix Corp.
|
Sep 20, 2016 04:32PM
|
|
Re: RVX Announces 2nd Positive Recommendation From DSMB
|
3
|
Resverlogix Corp.
|
Dec 05, 2016 01:18PM
|
|
ESC Poster on BETonMACE Design and Baseline Data
|
3
|
Resverlogix Corp.
|
Sep 02, 2019 08:37AM
|
|
Re: Zenith website undergoing changes
|
3
|
Zenith Epigenetics
|
Mar 05, 2016 03:30PM
|
